Read + Share
Amedeo Smart
Independent Medical Education
Basaranoglu M, Kapsigay M, Kunduz E. Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine. Eur J Gastroenterol Hepatol 2020;32:763.PMID: 32355096
Email
LinkedIn
Facebook
Twitter
Privacy Policy